NCT00633438 - Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery | Biotech Hunter

Enrollment

204

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

June 30, 2004

Conditions

Arthroscopy

Interventions

OTHER

Placebo

Matched oral capsule administered 1 hour prior to surgery and matched oral capsule administered post surgery as needed

DRUG

Celecoxib

400 mg oral capsule as single dose administered 1 hour prior to surgery and 200 mg oral capsule as single dose administered post surgery as needed

Trial Locations (18)

21093

Pfizer Investigational Site, Timonium

21218

Pfizer Investigational Site, Baltimore

29110

Pfizer Investigational Site, Orangeburg

29202

Pfizer Investigational Site, Columbia

29204

Pfizer Investigational Site, Columbia

29212

Pfizer Investigational Site, Columbia

33713

Pfizer Investigational Site, St. Petersburg

37601

Pfizer Investigational Site, Johnson City

65807

Pfizer Investigational Site, Springfield

78205

Pfizer Investigational Site, San Antonio

78209

Pfizer Investigational Site, San Antonio

78229

Pfizer Investigational Site, San Antonio

78240

Pfizer Investigational Site, San Antonio

85023

Pfizer Investigational Site, Phoenix

01104

Pfizer Investigational Site, Springfield

01107

Pfizer Investigational Site, Springfield

01109

Pfizer Investigational Site, Springfield

01199

Pfizer Investigational Site, Springfield

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY